Full Press Release Details
______________________________________________________________________________________________________
ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS TO BE HELD
NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS
MANAGEMENT INFORMATION CIRCULAR
________________________________________________________
This Notice and Management Information Circular,
along with accompanying materials, require your immediate attention.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE IN FAVOUR OF ALL PROPOSED RESOLUTIONS.
YOUR VOTE IS IMPORTANT. PLEASE VOTE TODAY.
NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS
NOTICE IS HEREBY GIVEN that the annual and special meeting of shareholders of Aeterna Zentaris Inc. (the "Corporation" or "Aeterna Zentaris") will be held at the offices of Norton Rose Fulbright Canada LLP, located at 1 Place Ville Marie, Suite 2500, Montreal, Quebec, Canada, on Friday, May 8, 2015, at 10:30 a.m. (Montreal time) for the following purposes:
The record date for the determination of shareholders of Aeterna Zentaris entitled to receive notice of and to vote at the meeting is March 16, 2015.
As shareholders of Aeterna Zentaris, it is very important that you read these materials carefully and vote your shares, either by proxy or in person at the meeting.
The following pages tell you more about how to exercise your right to vote your shares and provide additional information relating to the matters to be dealt with at the meeting.
By order of the Board of Directors,
/s/ Philip A. Theodore
Montreal, Quebec, Canada, March 17, 2015
Shareholders unable to attend the meeting are requested to complete and sign the enclosed form of proxy and return it in the stamped envelope provided. To be valid, proxies must reach the office of Computershare Trust Company of Canada, Share Ownership Management, 1500 University Street, 7th Floor, Montreal, Quebec, H3A 3S8, no later than forty-eight (48) hours (excluding Saturdays, Sundays and holidays) prior to the close of business on the date of the meeting or any adjournment or postponement thereof. The time limit for the deposit of proxies may be waived by the Chair of the Meeting without notice.
Aeterna Zentaris Inc., 1405 du Parc-Technologique Boulevard, Quebec City, Quebec, Canada, G1P 4P5
MANAGEMENT INFORMATION CIRCULAR
| SECTION 1. INTRODUCTION | 1 |
| SECTION 2. INFORMATION CONCERNING VOTING AT THE MEETING | 1 |
| 2.1 Your Vote is Important | 1 |
| 2.2 Voting | 1 |
| 2.3 How to Vote-Registered Shareholders | 2 |
| 2.4 How to Vote-Non-Registered Shareholders | 3 |
| 2.5 Completing the Form of Proxy | 3 |
| 2.6 Changing your Vote | 4 |
| SECTION 3. VOTING SHARES, QUORUM AND PRINCIPAL SHAREHOLDERS | 4 |
| 3.1 Voting Shares and Quorum | 4 |
| 3.2 Principal Shareholders | 4 |
| SECTION 4. PRESENTATION OF THE FINANCIAL STATEMENTS | 4 |
| SECTION 5. ELECTION OF DIRECTORS | 4 |
| SECTION 6. DISCLOSURE OF COMPENSATION | 6 |
| 6.1 Remuneration of Directors | 6 |
| 6.2 Compensation of Executive Officers | 9 |
| 6.3 Compensation Discussion & Analysis | 10 |
| 6.4 Incentive Plan Awards - Value Vested or Earned During the Year | 19 |
| 6.5 Other Forms of Compensation | 19 |
| 6.6 Securities Authorized for Issuance under Equity Compensation Plans | 21 |
| 6.7 Performance Graph | 21 |
| 6.8 Summary | 22 |
| SECTION 7. EMPLOYMENT AND CHANGE OF CONTROL AGREEMENTS | 23 |
| SECTION 8. APPOINTMENT OF AUDITORS AND AUDIT COMMITTEE DISCLOSURE | 25 |
| 8.1 Appointment of Auditors | 25 |
| 8.2 Audit Committee Disclosure | 25 |
| 8.3 Composition of the Audit Committee | 25 |
| 8.4 Education and Relevant Experience | 25 |
| 8.5 Pre-Approval Policies and Procedures | 26 |
| 8.6 External Auditor Service Fees | 27 |
| SECTION 9. PROPOSED SHARE CONSOLIDATION BY WAY OF ARTICLES OF AMENDMENT | 27 |
| 9.1 Introduction | 27 |
| 9.2 Background and Reasons for the Share Consolidation | 28 |
| 9.3 Shareholder Approval Requirement for the Share Consolidation | 28 |
| 9.4 Certain Risk Factors Associated with the Share Consolidation | 28 |
| 9.5 Effects of the Share Consolidation | 29 |
| 9.6 Effect of Share Consolidation on Convertible Securities | 29 |
| 9.7 Effect on Share Certificates | 29 |
| 9.8 No Fractional Shares | 30 |
| 9.9 No Dissent Rights | 30 |
| 9.10 Accounting Consequences | 30 |
| 9.11 Certain Tax Consequences of the Share Consolidation | 30 |
| 9.12 Special Resolution | 33 |
| SECTION 10. STATEMENT OF CORPORATE GOVERNANCE PRACTICES | 33 |
| SECTION 11. INDEBTEDNESS OF DIRECTORS AND OFFICERS | 33 |
| SECTION 12. INTEREST OF INFORMED PERSONS IN MATERIAL TRANSACTIONS | 34 |
| SECTION 13. SHAREHOLDER PROPOSALS FOR NEXT ANNUAL MEETING OF SHAREHOLDERS | 34 |
| SECTION 14. ADDITIONAL INFORMATION | 34 |
| SECTION 15. MAIL SERVICE INTERRUPTION | 34 |
| SECTION 16. DIRECTORS' APPROVAL | 35 |
| SCHEDULES: | |
| Schedule A: Statement of Corporate Governance Practices | A-1 |
| Schedule B: Mandate of the Board of Directors | B-1 |
| Schedule C: Audit Committee Charter | C-1 |
| Schedule D: Mandate of the Nominating, Governance and Compensation Committee | D-1 |
| Schedule E: Code of Ethical Conduct | E-1 |
MANAGEMENT INFORMATION CIRCULAR
SECTION 1. INTRODUCTION
This management information circular (the "Circular") is being furnished in connection with the solicitation of proxies by and on behalf of the management of Aeterna Zentaris Inc. ("we" or "our") for use at the annual meeting of our shareholders (the "Meeting") and any adjournment(s) or postponement(s) thereof. No person has been authorized to give any information or make any representation in connection with any matters to be considered at the Meeting other than those contained in this Circular and, if given or made, any such information or representation must not be relied upon as having been authorized.
In addition to solicitation by mail, our employees or our agents, we may solicit proxies by telephone or by other means. We will bear the entire cost of any such solicitation. We may also reimburse brokers and other persons holding our common shares (the "Common Shares") in their names, or in the names of nominees, for their costs incurred in sending proxy materials to beneficial or non-registered owners and obtaining their proxies or voting instructions. We have appointed The Laurel Hill Advisory Group Company ("Laurel Hill") as our soliciting agent. For this service, and other advisory services, we will pay up to CAN$30,000 and we will reimburse Laurel Hill for its out-of-pocket expenses.
Information contained in this Circular is given as of March 17, 2015 unless otherwise specifically stated. Our directors and executive officers are generally paid in their home country currency. Unless otherwise indicated, all compensation information included in this Circular is presented in US dollars and, to the extent a director or officer has been paid in a currency other than US dollars (Canadian dollars or euros), the amounts have been converted from such person's home country currency to US dollars based on the following annual average exchange rates: for the financial year ended December 31, 2014: 1.000 = US$1.329 and CAN$1.000 = US$0.905; for the financial year ended December 31, 2013: 1.000 = US$1.329 and CAN$1.000 = US$0.971; and for the financial year ended December 31, 2012: 1.000 = US$1.286 and CAN$1.000 = US$1.001.
SECTION 2. INFORMATION CONCERNING VOTING AT THE MEETING
2.1 Your Vote is Important
As a shareholder, it is very important that you read the following information on how to vote your Common Shares, either by proxy or in person at the Meeting. The materials are being sent to both our registered and non-registered shareholders. Please return your proxy as specified in this Circular and in the form of proxy.
You can attend the Meeting or you can appoint someone else to vote for you as your proxyholder. A shareholder entitled to vote at the Meeting may, by means of a proxy, appoint a proxyholder or one or more alternate proxyholders, who are not required to be shareholders, to attend and act at the Meeting in the manner and to the extent authorized by the proxy and with the authority conferred by the proxy. Voting by proxy means that you are giving the person named on your form of proxy the authority to vote your Common Shares for you at the Meeting and at any adjournment or postponement thereof.
You can choose from among four different ways to vote your Common Shares by proxy:
The persons who are named on the form of proxy are our directors and will vote your shares for you. You have the right to appoint someone else to be your proxyholder. If you appoint someone else, he or she must attend the Meeting to vote your Common Shares.
2.3 How to Vote - Registered Shareholders
You are a registered shareholder if your name appears on your share certificate or on the register of shareholders maintained by our registrar and transfer agent. If you are not sure whether you are a registered shareholder, please contact Computershare Trust Company of Canada ("Computershare") by telephone toll-free at 1-800-564-6253 or by e-mail at service@computershare.com.
Voting by proxy using the telephone is only available to shareholders located in Canada and the United States. Call 1-866-732-VOTE (8683) toll-free in Canada and 1-312-588-4290 toll-free in the United States from a touchtone telephone and follow the instructions provided. Your voting instructions are then conveyed by using touchtone selections over the telephone.
You will need your Control Number located on your form of proxy or in the e-mail addressed to you if you have chosen to receive this Circular electronically.
If you choose the telephone, you cannot appoint any person other than the directors named on your form of proxy as your proxyholder.
The cut-off time for voting by telephone is 5:00 p.m. (Eastern Time) on May 6, 2015.
Complete, date and sign your form of proxy and fax it to Computershare Trust Company of Canada, Attention: Proxy Department at 1-866-249-7775 (toll free in North America) or 416-263-9524 (international).
If you return your proxy by fax, you can appoint a person other than the directors named in the form of proxy as your proxyholder. This person does not have to be a shareholder. Fill in the name of the person you are appointing in the blank space provided on the form or proxy. Complete your voting instruction on the form of proxy, and date and sign the form. Make sure that the person you appoint is aware that he or she has been appointed and attends the Meeting.
The cut-off time for voting by fax is 5:00 p.m. (Eastern Time) on May 6, 2015.
Go to the website www.investorvote.com and follow the instructions on the screen. Your voting instructions are then conveyed electronically over the Internet.
You will need your Control Number located on your form of proxy or in the e-mail addressed to you if you have chosen to receive this Circular electronically.
If you return your proxy via the Internet, you can appoint a person other than the Directors named in the form of proxy as your proxyholder. This person does not have to be a shareholder. Indicate the name of the person you are appointing by following the instructions online.
The cut-off time for voting over the Internet is 5:00 p.m. (Eastern Time) on May 6, 2015.
Complete, date and sign your form of proxy and return it in the envelope provided to you or deliver it to one of Computershare's principal offices in Calgary, Halifax, Montreal, Toronto, Vancouver or Winnipeg for receipt before 5:00 p.m. (Eastern time) on May 6, 2015 or with the Secretary of the Meeting prior to commencement of the Meeting on the day of the Meeting or on the day of any adjournment or postponement thereof. A list of addresses for the principal offices of Computershare is set forth on page 34 of this Circular.
If you return your proxy by mail, you can appoint a person other than the directors or officers named in the form of proxy as your proxyholder. This person does not have to be a shareholder. Fill in the name of the person you are appointing in the blank space provided on the form of proxy. Complete your voting instruction on the form of proxy, and date and sign the form. Make sure that the person you appoint is aware that he or she has been appointed and attends the Meeting.
See the section titled "Completing the Form of Proxy" for more information.
In Person at the Meeting
You do not need to complete or return your form of proxy.
You will be required to register your attendance for the Meeting with the scrutineer at the registration desk.
2.4 How to Vote - Non-Registered Shareholders
The information set forth in this section should be reviewed carefully by non-registered shareholders of the Corporation. Shareholders who do not hold their shares in their own name should note that only proxies deposited by shareholders who appear on the records maintained by our registrar and transfer agent as registered holders of shares will be recognized and acted upon at the Meeting.
You are a non-registered shareholder (a "Beneficial Shareholder") if your bank, trust company, securities broker or dealer or other financial institution or intermediary ("your nominee") holds your Common Shares for you. If you are not sure whether you are a non-registered shareholder, please contact Computershare by telephone at 1-514-982-7555 or toll-free at 1-800-564-6253 or by e-mail at service@computershare.com.
Beneficial Shareholders will receive from their nominee either voting instruction forms or, less frequently, forms of proxy. The purpose of these forms is to permit Beneficial Shareholders to direct the voting of the Common Shares they beneficially own. Beneficial Shareholders should follow the procedures set out on the voting instruction form or form of proxy they receive. Every nominee has its own mailing procedures and provides its own return instructions to clients. The majority of nominees now delegate responsibility for obtaining voting instructions from clients to Broadridge Financial Solutions, Inc. in Canada and its counterpart in the United States ("Broadridge").
If you receive a voting instruction form from Broadridge, the voting instruction form must be completed and returned to Broadridge, in accordance with Broadridge's instructions, well in advance of the Meeting in order to: (a) have your Common Shares voted, as per your instructions, at the Meeting; or (b) arrange to have an alternate representative duly appointed by you attend the Meeting and vote your Common Shares at the Meeting.
A voting instruction form allows you to provide your voting instructions via the Internet, by telephone or by mail. You will need your Control Number found on your voting instruction form, if you choose to vote on the Internet or by telephone. Alternatively, non-registered shareholders may complete the voting instruction form and return it by mail, as directed in the voting instruction form.
Additionally, there are two kinds of Beneficial Shareholders: (i) those who object to their name being made known to the issuers of securities which they own, known as objecting beneficial owners or "OBOs"; and (ii) those who do not object to their name being made known to the issuers of securities which they own, known as non-objecting beneficial owners or "NOBOs".
Aeterna Zentaris may utilize the Broadridge Quickvote service to assist NOBOs with voting their Common Shares. NOBOs may be contracted by Laurel Hill to conveniently obtain a vote directly over the telephone.
Should a Beneficial Shareholder who receives one of the above forms wish to vote at the Meeting in person, the Beneficial Shareholder should strike out the names of the management designees and insert the Beneficial Shareholder's name in the blank space provided. In either case, Beneficial Shareholders should carefully follow the instructions of their nominee, including those regarding when and where the proxy or voting instruction form is to be delivered.
We intend to pay for proximate intermediaries to send the proxy-related materials to OBOs.
All references to "shareholders" in this Circular are to registered shareholders unless specifically stated otherwise.
2.5 Completing the Form of Proxy
You can choose to vote "FOR" or "WITHHOLD" with respect to the election of directors and the appointment of auditors and "FOR" or "AGAINST" with respect to the Special Resolution on our proposed Share Consolidation and all other matters to be voted upon. If you are a non-registered shareholder voting your Common Shares, please follow the instructions provided in the voting instruction form that you should have received together with this Circular.
When you sign the form of proxy without appointing an alternate proxyholder, you authorize David A. Dodd and Carolyn Egbert, respectively the Chairman of our Board of Directors and Chair of our Nominating, Governance and Compensation Committee, to vote your Common Shares for you at the Meeting in accordance with your instructions.
Management is not aware of any other matters that will be presented for action at the Meeting. If, however, other matters properly come before the Meeting, the persons designated in the enclosed form of proxy will vote in accordance with their judgment, pursuant to the discretionary authority conferred by the proxy with respect to such matters.
You have the right to appoint someone other than the management proxy nominees to be your proxyholder. If you are appointing someone else to vote your Common Shares for you at the Meeting, fill in the name of the person voting for you in the blank space provided on the form of proxy.
If you do not specify how you want your Common Shares voted, your proxyholder will vote your shares in favour of each item scheduled to come before the Meeting, including all amendments or variations thereto, and as he or she sees fit on any other matter that may properly come before the Meeting.
A proxyholder has the same rights as the shareholder by whom it was appointed to speak at the Meeting in respect of any matter, to vote by way of ballot at the Meeting and, except where a proxyholder has conflicting instructions from more than one shareholder, to vote at the Meeting in respect of any matter by way of show of hands.
If you are an individual shareholder, you or your authorized attorney must sign the form of proxy. If you are a corporation, partnership, trust or other legal entity, an authorized officer, representative or attorney must sign the form of proxy.
2.6 Changing your Vote
In addition to revocation in any other manner permitted by law, a shareholder giving a proxy and submitting it by mail may revoke it by an instrument in writing executed by the shareholder or the shareholder's attorney authorized in writing and deposited either at the Montreal office of our registrar and transfer agent, Computershare, located at 1500 Robert-Bourassa Boulevard, 7th Floor, Montreal, Quebec, Canada, H3A 3S8, or at our registered office, located at 1405 du Parc-Technologique Boulevard, Quebec City, Quebec, Canada, G1P 4P5, at any time up to and including the last business day preceding the day of the Meeting, or any adjournment or postponement thereof, at which the proxy is to be used, or with the Chair of the Meeting on the day of the Meeting, or any adjournment or postponement thereof. If the voting instructions were conveyed by telephone or over the Internet, conveying new voting instructions by any of these two means or by mail within the applicable cut-off times will revoke the prior instructions.
SECTION 3. VOTING SHARES, QUORUM AND PRINCIPAL SHAREHOLDERS
3.1 Voting Shares and Quorum
Shareholders of record on March 16, 2015 are entitled to receive notice of and vote at the Meeting. As of March 16, 2015, there were 90,557,142 issued and outstanding Common Shares. The list of shareholders entitled to vote at the Meeting will be available for inspection on and after March 16, 2015 during usual business hours at the Montreal office of our registrar and transfer agent, Computershare, located at 1500 University Street, 7th Floor, Montreal, Quebec, H3A 3S8, as well as at the Meeting. The holders of the Common Shares are entitled to one vote for each Common Share held by them at all meetings of shareholders.
Our By-Law One provides that a quorum is present at the Meeting if the holder(s) of 10% or more of the issued and outstanding Common Shares are present in person or represented by proxy, irrespective of the number of shareholders actually in attendance at the Meeting.
3.2 Principal Shareholders
As of March 16, 2015, to the knowledge of our officers and directors based on shareholders' public filings, there are no persons or entities that beneficially owned, or exercised control or direction over, directly or indirectly, 10% or more of the votes attached to the Common Shares.
SECTION 4. PRESENTATION OF THE FINANCIAL STATEMENTS
Our audited consolidated financial statements as at December 31, 2014 and December 31, 2013 and for the years ended December 31, 2014, 2013, 2012 and the auditors' report thereon will be submitted at the Meeting.
SECTION 5. ELECTION OF DIRECTORS
Our Articles provide that our Board of Directors (the "Board") shall be composed of a minimum of five and a maximum of 15 directors. Directors are elected annually by our shareholders, but the directors may from time to time appoint one or more directors, provided that the total number of directors so appointed does not exceed one-third (1/3) of the number of directors elected at the last annual meeting of shareholders. Management proposes the six persons named in the table below (and in the form of proxy or voting instruction form enclosed together with this Circular) as candidates for election as directors. Each elected director will
remain in office until termination of the next annual meeting of shareholders or until his or her successor is duly elected or appointed, unless his or her post is vacated earlier. Each of the candidates proposed by management is currently a director. As you will note from the enclosed form of proxy or voting instruction form, shareholders may vote for each director individually, and thus there is no slate vote.
Our Board of Directors currently consists of seven members. Mr. Jos P. Dorais, one of our current directors, will not stand for re-election and will retire from our Board of Directors at the Meeting. Our Board of Directors does not intend to appoint or to propose for election an additional director following Mr. Dorais' retirement from our Board but may do so in the future.
In accordance with a majority voting policy adopted by our Board, in an uncontested election of directors, a nominee for election as a director who receives a greater number of votes "withheld" than votes "for" his or her nomination will be expected to offer to tender his or her resignation to the Board promptly following the meeting of shareholders at which the director is elected. The Nominating, Governance and Compensation Committee (the "Governance Committee") will consider such offer and make a recommendation to the Board as to whether to accept such resignation. The Board will make its final decision and announce it in a press release within 90 days following the meeting of shareholders. The director who offers to tender his or her resignation pursuant to this policy will not participate in any committee or Board deliberations and decisions pertaining to the resignation offer.
Unless instructions are given to abstain from voting with regard to the election of directors, the persons whose names appear on the enclosed form of proxy will vote in favour of the election of the six nominees whose names are set out in the table below. Management does not foresee that any of the nominees listed below will be unable or, for any reason, unwilling to perform his or her duties as a director. In the event that the foregoing occurs for any reason, prior to the election, the persons indicated on the enclosed form of proxy reserve the right to vote for another candidate of their choice unless otherwise instructed by the shareholder in the form of proxy to abstain from voting on the election of directors.
| Name and Place of Residence | Principal Occupation | Director since | Number of Common Shares Held (1) | |||
| Aubut, Marcel Quebec, Canada | Partner, Vice-Chairman of the Board BCF LLP (law firm) | 1996 | 18,750 | |||
| Dodd, David A. South Carolina, USA | Chairman, President and Chief Executive Officer Aeterna Zentaris Inc. | 2013 | 270,333 | |||
| Egbert, Carolyn (2) Texas, USA | Corporate Director | 2012 | 192,000 | |||
| Ernst, Juergen (2) Brussels, Belgium | Lead Director Aeterna Zentaris Inc. Corporate Director Former General Manager Pharmaceutical Sector of Solvay S.A. (international chemical and pharmaceutical group) | 2005 | 134,808 | |||
| Lapalme, Pierre (3) Quebec, Canada | Corporate Director | 2009 | - | |||
| Limoges, G rard (3) Quebec, Canada | Corporate Director Former Deputy Chairman of Ernst & Young LLP Canada (accounting firm) | 2004 | 1,499 |
_________________________
To the knowledge of our directors and officers, no proposed director, except as described below:
SECTION 6. DISCLOSURE OF COMPENSATION
6.1 Remuneration of Directors
The compensation paid to members of our Board of Directors who are not our employees (our "Outside Directors") is designed to (i) attract and retain the most qualified people to serve on the Board and its committees, (ii) align the interests of the Outside Directors with those of our shareholders, and (iii) provide appropriate compensation for the risks and responsibilities related to being an effective Outside Director. This compensation is recommended to the Board by the Governance Committee. The Governance Committee is composed of three Outside Directors, each of whom is independent, namely Ms. Carolyn Egbert (Chair), Mr. Juergen Ernst and Mr. Jos P. Dorais.
The Board has adopted a formal mandate for the Governance Committee, which is attached as Schedule D to this Circular and is also available on our website at www.aezsinc.com. The mandate of the Governance Committee provides that it is responsible for, among other matters, assisting the Board in developing our approach to corporate governance issues, proposing new Board nominees, overseeing the assessment of the effectiveness of the Board and its committees, their respective chairs and individual directors, making recommendations to the Board with respect to directors' compensation and generally playing a leadership role in our corporate governance practices.
In 2013, the Governance Committee retained James F. Reda and Associates ("Reda"), a division of Gallagher Benefit Services, Inc., as a compensation consultant. Reda was retained to assist the Governance Committee with (i) a review of our compensation programs, particularly our executive short-term and long-term incentive programs and (ii) a review and benchmarking of the remuneration of our Outside Directors. Reda analyzed our past practices and defined a peer group of companies in order to
understand the competitive compensation practices and to propose a program designed to deliver both cash and equity compensation components to our Outside Directors and executive officers that was competitive with the peer group of companies. Our existing Outside Director compensation structure was benchmarked against market compensation data gathered from North American biopharmaceutical companies of comparable size. See Section 6.2.1.2, "Compensation Consultant" and Section 6.3.3, "Benchmarking" for more information.
Based on the results of the benchmarking study and in light of the substantial responsibilities inherent to the position of director, Reda proposed that we increase Outside Director compensation, including both cash and equity components. Upon recommendation of the Governance Committee, the Board determined in 2013 not to implement any increase to the remuneration payable to Outside Directors and deferred further consideration of various elements of Outside Directors' compensation to a later point in time in 2014. During 2014, Mr. David A. Dodd, our President and Chief Executive Officer, was appointed Chairman of our Board of Directors. Following his appointment, our Board established the position of "Lead Independent Director" or Lead Director and fixed the compensation of the Lead Director at 40,000, payable in the Lead Director's home country currency.
6.1.1 Annual Retainers and Attendance Fees
Annual retainers and attendance fees are paid on a quarterly basis to our Outside Directors on the following basis:
| Type of Compensation | Annual Compensation for the year 2014 (in units of home country currency) | |
| Lead Director Retainer | 40,000 | |
| Board Member Retainer | 15,000 | |
| Board Meeting Attendance Fees | 1,000 per meeting | |
| Audit Committee Chair Retainer | 15,000 | |
| Audit Committee Member Retainer | 4,000 | |
| Audit Committee Meeting Attendance Fees | 1,000 per meeting | |
| Governance Committee Chair Retainer | 12,000 | |
| Governance Committee Member Retainer | 2,000 | |
| Governance Committee Meeting Attendance Fees | 1,000 per meeting |
All amounts in the above table are paid to Board and committee members in their home country currency.